Tekla Capital Management as of Sept. 30, 2017
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 152 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 8.1 | $227M | 2.8M | 81.02 | |
| Celgene Corporation | 7.2 | $202M | 1.4M | 145.82 | |
| Biogen Idec (BIIB) | 5.5 | $153M | 490k | 313.12 | |
| Amgen (AMGN) | 4.1 | $116M | 620k | 186.45 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.0 | $111M | 731k | 152.04 | |
| Alexion Pharmaceuticals | 3.8 | $105M | 751k | 140.29 | |
| Johnson & Johnson (JNJ) | 3.7 | $104M | 799k | 130.01 | |
| Merck & Co (MRK) | 3.4 | $94M | 1.5M | 64.03 | |
| Incyte Corporation (INCY) | 2.9 | $81M | 693k | 116.74 | |
| Regeneron Pharmaceuticals (REGN) | 2.7 | $76M | 171k | 447.12 | |
| Allergan | 2.5 | $70M | 339k | 204.95 | |
| Abbott Laboratories (ABT) | 2.4 | $67M | 1.3M | 53.36 | |
| Illumina (ILMN) | 2.3 | $63M | 317k | 199.20 | |
| UnitedHealth (UNH) | 1.9 | $54M | 276k | 195.85 | |
| Mylan Nv | 1.8 | $50M | 1.6M | 31.37 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $47M | 502k | 93.07 | |
| Medtronic (MDT) | 1.6 | $45M | 580k | 77.77 | |
| Thermo Fisher Scientific (TMO) | 1.5 | $41M | 219k | 189.20 | |
| Jazz Pharmaceuticals (JAZZ) | 1.4 | $40M | 274k | 146.25 | |
| Shire | 1.4 | $39M | 252k | 153.14 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $35M | 563k | 61.28 | |
| Novartis (NVS) | 1.2 | $34M | 399k | 85.85 | |
| CVS Caremark Corporation (CVS) | 1.2 | $34M | 412k | 81.32 | |
| Eli Lilly & Co. (LLY) | 1.2 | $33M | 388k | 85.54 | |
| Teva Pharmaceutical Industries (TEVA) | 1.1 | $31M | 1.8M | 17.60 | |
| Humana (HUM) | 1.1 | $30M | 125k | 243.63 | |
| Pfizer (PFE) | 1.0 | $29M | 810k | 35.70 | |
| Sarepta Therapeutics (SRPT) | 0.9 | $24M | 537k | 45.36 | |
| AmerisourceBergen (COR) | 0.8 | $24M | 288k | 82.75 | |
| Centene Corporation (CNC) | 0.8 | $22M | 230k | 96.77 | |
| McKesson Corporation (MCK) | 0.8 | $22M | 143k | 153.61 | |
| IDEXX Laboratories (IDXX) | 0.7 | $21M | 132k | 155.49 | |
| SPDR S&P Biotech (XBI) | 0.7 | $20M | 227k | 86.57 | |
| CIGNA Corporation | 0.7 | $19M | 100k | 186.94 | |
| Nevro (NVRO) | 0.6 | $18M | 195k | 90.88 | |
| Pieris Pharmaceuticals (PIRS) | 0.6 | $16M | 2.8M | 5.76 | |
| AstraZeneca (AZN) | 0.5 | $15M | 443k | 33.88 | |
| GlaxoSmithKline | 0.5 | $15M | 359k | 40.60 | |
| Omega Healthcare Investors (OHI) | 0.5 | $15M | 459k | 31.91 | |
| Charles River Laboratories (CRL) | 0.5 | $14M | 127k | 108.02 | |
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $14M | 115k | 117.49 | |
| Medical Properties Trust (MPW) | 0.5 | $13M | 1.0M | 13.13 | |
| Acadia Healthcare (ACHC) | 0.5 | $13M | 272k | 47.76 | |
| Senior Housing Properties Trust | 0.5 | $13M | 647k | 19.55 | |
| Puma Biotechnology (PBYI) | 0.5 | $13M | 106k | 119.75 | |
| Welltower Inc 6.50% pfd prepet | 0.5 | $13M | 200k | 63.43 | |
| Seattle Genetics | 0.4 | $12M | 224k | 54.41 | |
| Sabra Health Care REIT (SBRA) | 0.4 | $12M | 551k | 21.94 | |
| Ventas (VTR) | 0.4 | $12M | 176k | 65.13 | |
| Edwards Lifesciences (EW) | 0.4 | $11M | 97k | 109.31 | |
| Dermira | 0.4 | $11M | 397k | 27.00 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.4 | $10M | 13M | 0.79 | |
| Exelixis (EXEL) | 0.3 | $9.4M | 389k | 24.23 | |
| Physicians Realty Trust | 0.3 | $9.4M | 531k | 17.73 | |
| Diplomat Pharmacy | 0.3 | $9.6M | 462k | 20.71 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $9.6M | 530k | 18.17 | |
| Merus N V (MRUS) | 0.3 | $9.5M | 479k | 19.87 | |
| Abbvie (ABBV) | 0.3 | $9.3M | 105k | 88.86 | |
| Sanofi-Aventis SA (SNY) | 0.3 | $9.0M | 180k | 49.79 | |
| NuVasive | 0.3 | $9.0M | 162k | 55.46 | |
| Cellectis S A (CLLS) | 0.3 | $8.8M | 310k | 28.45 | |
| Epizyme | 0.3 | $8.7M | 456k | 19.05 | |
| Karyopharm Therapeutics (KPTI) | 0.3 | $8.3M | 757k | 10.98 | |
| Anthem (ELV) | 0.3 | $8.5M | 45k | 189.88 | |
| Zimmer Holdings (ZBH) | 0.3 | $7.9M | 68k | 117.09 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $7.9M | 149k | 53.26 | |
| Endo International (ENDPQ) | 0.3 | $7.8M | 915k | 8.56 | |
| Pra Health Sciences | 0.3 | $7.8M | 102k | 76.17 | |
| Hca Holdings (HCA) | 0.3 | $7.6M | 95k | 79.60 | |
| Tesaro | 0.3 | $7.4M | 58k | 129.11 | |
| Adaptimmune Therapeutics (ADAP) | 0.3 | $7.7M | 935k | 8.19 | |
| Intercept Pharmaceuticals In | 0.3 | $7.2M | 123k | 58.04 | |
| Wright Medical Group Nv | 0.2 | $6.9M | 267k | 25.87 | |
| LTC Properties (LTC) | 0.2 | $6.4M | 136k | 46.98 | |
| Entellus Medical Cm | 0.2 | $6.3M | 342k | 18.46 | |
| Flamel Technologies Sa (AVDL) | 0.2 | $6.6M | 624k | 10.50 | |
| Valeant Pharmaceuticals Int | 0.2 | $6.1M | 425k | 14.33 | |
| Clovis Oncology | 0.2 | $6.2M | 75k | 82.40 | |
| Natera (NTRA) | 0.2 | $6.3M | 486k | 12.89 | |
| Myovant Sciences | 0.2 | $6.2M | 400k | 15.47 | |
| Tetraphase Pharmaceuticals | 0.2 | $5.9M | 859k | 6.84 | |
| Ra Pharmaceuticals | 0.2 | $5.8M | 396k | 14.60 | |
| Universal Health Services (UHS) | 0.2 | $5.3M | 48k | 110.95 | |
| Dex (DXCM) | 0.2 | $5.3M | 108k | 48.92 | |
| Express Scripts Holding | 0.2 | $5.4M | 85k | 63.33 | |
| New Senior Inv Grp | 0.2 | $5.2M | 568k | 9.15 | |
| Intercept Pharmas conv | 0.2 | $5.3M | 6.9M | 0.77 | |
| Cardinal Health (CAH) | 0.2 | $5.1M | 77k | 66.92 | |
| Henry Schein (HSIC) | 0.2 | $5.1M | 63k | 81.99 | |
| United Therapeutics Corporation (UTHR) | 0.2 | $5.2M | 44k | 117.19 | |
| Foamix Pharmaceuticals | 0.2 | $5.2M | 930k | 5.55 | |
| Stryker Corporation (SYK) | 0.2 | $4.5M | 32k | 142.03 | |
| Amicus Therapeutics (FOLD) | 0.1 | $4.2M | 276k | 15.08 | |
| Verona Pharma Plc ads (VRNA) | 0.1 | $4.2M | 275k | 15.35 | |
| Novo Nordisk A/S (NVO) | 0.1 | $3.5M | 74k | 48.15 | |
| Ardelyx (ARDX) | 0.1 | $3.6M | 639k | 5.60 | |
| Allergan Plc pfd conv ser a | 0.1 | $3.7M | 5.0k | 737.80 | |
| Innoviva (INVA) | 0.1 | $3.5M | 249k | 14.12 | |
| Egalet Corporation note 5.50% 4/1/20 | 0.1 | $3.6M | 7.0M | 0.51 | |
| Amarin Corporation (AMRN) | 0.1 | $3.3M | 956k | 3.50 | |
| Accelr8 Technology | 0.1 | $3.4M | 150k | 22.45 | |
| Perrigo Company (PRGO) | 0.1 | $3.2M | 37k | 84.64 | |
| Affimed Therapeutics B V | 0.1 | $3.2M | 1.4M | 2.25 | |
| Momenta Pharmaceuticals | 0.1 | $2.8M | 153k | 18.50 | |
| Achillion Pharmaceuticals | 0.1 | $2.8M | 616k | 4.49 | |
| GenMark Diagnostics | 0.1 | $2.8M | 295k | 9.63 | |
| Tenet Healthcare Corporation (THC) | 0.1 | $2.7M | 165k | 16.43 | |
| Impax Laboratories | 0.1 | $2.5M | 124k | 20.30 | |
| Juno Therapeutics | 0.1 | $2.6M | 57k | 44.87 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $2.6M | 500k | 5.15 | |
| Healthcare Realty Trust Incorporated | 0.1 | $2.2M | 68k | 32.34 | |
| Mallinckrodt Pub | 0.1 | $2.3M | 62k | 37.37 | |
| Acceleron Pharma | 0.1 | $2.2M | 60k | 37.32 | |
| Uniqure Nv (QURE) | 0.1 | $2.3M | 241k | 9.60 | |
| Spark Therapeutics | 0.1 | $2.2M | 24k | 89.18 | |
| Evolent Health (EVH) | 0.1 | $2.2M | 123k | 17.80 | |
| Glaukos (GKOS) | 0.1 | $2.1M | 64k | 32.99 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.1 | $2.3M | 287k | 8.10 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $2.3M | 200k | 11.70 | |
| Nanostring Technologies (NSTGQ) | 0.1 | $1.8M | 114k | 16.16 | |
| Bluebird Bio (BLUE) | 0.1 | $1.8M | 13k | 137.35 | |
| Horizon Pharma | 0.1 | $2.1M | 163k | 12.68 | |
| Galapagos Nv- (GLPG) | 0.1 | $1.9M | 19k | 101.74 | |
| Global Blood Therapeutics In | 0.1 | $1.9M | 63k | 31.06 | |
| Cascadian Therapeutics | 0.1 | $1.9M | 454k | 4.09 | |
| Community Health Systems (CYH) | 0.1 | $1.6M | 204k | 7.68 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.7M | 323k | 5.24 | |
| Cymabay Therapeutics | 0.1 | $1.7M | 210k | 8.06 | |
| Argenx Se (ARGX) | 0.1 | $1.7M | 75k | 22.44 | |
| HCP | 0.1 | $1.3M | 46k | 27.82 | |
| Healthcare Tr Amer Inc cl a | 0.1 | $1.4M | 46k | 29.80 | |
| Welltower Inc Com reit (WELL) | 0.1 | $1.5M | 21k | 70.28 | |
| Ovid Therapeutics (OVID) | 0.1 | $1.4M | 163k | 8.57 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $1.0M | 350k | 2.95 | |
| Coherus Biosciences (CHRS) | 0.0 | $1.2M | 90k | 13.36 | |
| Adverum Biotechnologies | 0.0 | $1.1M | 300k | 3.65 | |
| Arca Biopharma | 0.0 | $892k | 811k | 1.10 | |
| Avexis | 0.0 | $967k | 10k | 96.70 | |
| Novavax | 0.0 | $651k | 571k | 1.14 | |
| Alliqua | 0.0 | $594k | 1.7M | 0.36 | |
| Xencor (XNCR) | 0.0 | $458k | 20k | 22.90 | |
| Quotient | 0.0 | $586k | 119k | 4.93 | |
| Auris Med Hldg | 0.0 | $635k | 775k | 0.82 | |
| Bellicum Pharma | 0.0 | $693k | 60k | 11.55 | |
| Global Medical Reit (GMRE) | 0.0 | $659k | 73k | 8.98 | |
| Ac Immune Sa (ACIU) | 0.0 | $462k | 41k | 11.29 | |
| Celldex Therapeutics | 0.0 | $303k | 106k | 2.86 | |
| Rmr Group Inc cl a (RMR) | 0.0 | $382k | 7.4k | 51.34 | |
| Eiger Biopharmaceuticals | 0.0 | $341k | 31k | 10.99 | |
| Zafgen | 0.0 | $47k | 13k | 3.53 | |
| Quorum Health | 0.0 | $123k | 24k | 5.18 | |
| Protagonist Therapeutics (PTGX) | 0.0 | $138k | 7.8k | 17.64 |
